Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jue Wang, Fenwei Wang, A. Kessinger (2010)
Outcome of Combined Hepatocellular and Cholangiocarcinoma of the LiverJournal of Oncology, 2010
M. Garancini, P. Goffredo, F. Pagni, F. Romano, S. Roman, J. Sosa, V. Giardini (2014)
Combined hepatocellular‐cholangiocarcinoma: A population‐level analysis of an uncommon primary liver tumorLiver Transplantation, 20
M. Wachtel, Yan Zhang, Tom Xu, M. Chiriva-Internati, E. Frezza (2008)
Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large DatabaseClinical Medicine. Pathology, 1
Kent Sato, R. Lewandowski, J. Bui, R. Omary, R. Hunter, L. Kulik, M. Mulcahy, David Liu, H. Chrisman, S. Resnick, A. Nemcek, R. Vogelzang, R. Salem (2006)
Treatment of Unresectable Primary and Metastatic Liver Cancer with Yttrium-90 Microspheres (TheraSphere®): Assessment of Hepatic Arterial EmbolizationCardioVascular and Interventional Radiology, 29
D. Al‐Adra, R. Gill, S.J. Axford, Xinzhe Shi, N. Kneteman, S. Liau (2015)
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysisEuropean Journal of Surgical Oncology, 41
G. Kim, H. Jeung, DoKyung Kim, Joo Kim, S. Yoon, E. Jung, S. Shin (2010)
A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic ChemotherapyCancer Research and Treatment : Official Journal of Korean Cancer Association, 42
A. Kennedy, S. Nag, R. Salem, R. Murthy, A. McEwan, C. Nutting, A. Benson, Joseph Espat, J. Bilbao, Ricky Sharma, James Thomas, D. Coldwell (2007)
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.International journal of radiation oncology, biology, physics, 68 1
ND Theise, O Nakashima, YN Park, Y Nakanuma (2010)
WHO classification of tumours of the digestive system
Cheong-Il Shin, Jeong Lee, Se Kim, Jin-Young Choi, Jae Lee, J. Han, Soo Jo, B. Choi (2007)
Recurrence Patterns of Combined Hepatocellular-Cholangiocarcinoma on Enhanced Computed TomographyJournal of Computer Assisted Tomography, 31
National Institutes of Health, National Cancer Institute. Common terminology criteria for adverse events (CTCAE)
M. Abdelmaksoud, J. Louie, N. Kothary, G. Hwang, W. Kuo, L. Hofmann, D. Hovsepian, D. Sze (2011)
Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization.Journal of vascular and interventional radiology : JVIR, 22 10
Kathryn Fowler, A. Sheybani, R. Parker, S. Doherty, Elizabeth Brunt, W. Chapman, C. Menias (2013)
Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.AJR. American journal of roentgenology, 201 2
M. Yeh (2010)
Pathology of combined hepatocellular‐cholangiocarcinomaJournal of Gastroenterology and Hepatology, 25
M. Chi, K. Mikhitarian, C. Shi, L. Goff (2012)
Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review.Gastrointestinal cancer research : GCR, 5 6
Theodora Potretzke, B. Tan, M. Doyle, E. Brunt, J. Heiken, Kathryn Fowler (2016)
Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.AJR. American journal of roentgenology, 207 1
S. Katyal, J. Oliver, M. Peterson, P. Chang, R. Baron, B. Carr (2000)
Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis.AJR. American journal of roentgenology, 175 6
E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, Lawrence Rubinstein, L. Shankar, L. Dodd, Robert Kaplan, D. Lacombe, J. Verweij (2009)
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).European journal of cancer, 45 2
M. Abdelmaksoud, J. Louie, N. Kothary, G. Hwang, W. Kuo, L. Hofmann, D. Hovsepian, D. Sze (2011)
Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization.Journal of vascular and interventional radiology : JVIR, 22 10
(2016)
of Health and Human Services, National Institutes of Health, National Cancer Institute
J. Valle, H. Wasan, D. Palmer, D. Cunningham, A. Anthoney, A. Maraveyas, S. Madhusudan, T. Iveson, S. Hughes, S. Pereira, M. Roughton, J. Bridgewater (2010)
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.The New England journal of medicine, 362 14
D. Coldwell, B. Sangro, H. Wasan, R. Salem, A. Kennedy (2011)
General Selection Criteria of Patients for Radioembolization of Liver Tumors: An International Working Group ReportAmerican Journal of Clinical Oncology, 34
A. Riaz, V. Gates, Bassel Atassi, R. Lewandowski, M. Mulcahy, R. Ryu, Kent Sato, Talia Baker, L. Kulik, Ramona Gupta, M. Abecassis, A. Benson, R. Omary, L. Millender, A. Kennedy, R. Salem (2011)
Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.International journal of radiation oncology, biology, physics, 79 1
G. Sapisochin, N. Fidelman, J. Roberts, F. Yao (2011)
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinomaLiver Transplantation, 17
A. Wee, B. Nilsson (1999)
Combined Hepatocellular-CholangiocarcinomaActa Cytologica, 43
R. Salem, Kenneth Thurston (2006)
Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations.Journal of vascular and interventional radiology : JVIR, 17 8
C. Panjala, D. Sénécal, M. Bridges, G. Kim, R. Nakhleh, J. Nguyen, D. Harnois (2010)
The Diagnostic Conundrum and Liver Transplantation Outcome for Combined Hepatocellular‐CholangiocarcinomaAmerican Journal of Transplantation, 10
R. Salem, R. Lewandowski, L. Kulik, E. Wang, A. Riaz, R. Ryu, Kent Sato, Ramona Gupta, P. Nikolaidis, F. Miller, V. Yaghmai, S. Ibrahim, S. Senthilnathan, Talia Baker, V. Gates, Bassel Atassi, S. Newman, Khairuddin Memon, Richard Chen, R. Vogelzang, A. Nemcek, S. Resnick, H. Chrisman, J. Carr, R. Omary, M. Abecassis, A. Benson, M. Mulcahy (2011)
Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.Gastroenterology, 140 2
Kent Sato, R. Omary, C. Takehana, S. Ibrahim, R. Lewandowski, R. Ryu, R. Salem (2009)
The role of tumor vascularity in predicting survival after yttrium-90 radioembolization for liver metastases.Journal of vascular and interventional radiology : JVIR, 20 12
J. Bruix, M. Sherman (2011)
Management of hepatocellular carcinoma: An updateHepatology (Baltimore, Md.), 53
G. Lin, C. Toh, R. Wu, S. Ko, S. Ng, W. Chou, J. Tseng (2007)
Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imagingInternational Journal of Clinical Practice, 62
T. Vogl, N. Naguib, N. Nour-Eldin, W. Bechstein, S. Zeuzem, J. Trojan, T. Gruber-Rouh (2012)
Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: Results and prognostic factors governing treatment successInternational Journal of Cancer, 131
R. Allen, J. Lisa (1949)
Combined liver cell and bile duct carcinoma.The American journal of pathology, 25 4
B. Sangro, L. Carpanese, R. Cianni, R. Golfieri, D. Gasparini, S. Ezziddin, P. Paprottka, F. Fiore, M. Buskirk, Jose Bilbao, Giuseppe Ettorre, R. Salvatori, E. Giampalma, O. Geatti, K. Wilhelm, Ralf Hoffmann, F. Izzo, M. Iñarrairaegui, Carlo Maini, C. Urigo, A. Cappelli, A. Vit, H. Ahmadzadehfar, Tobias Jakobs, S. Lastoria (2011)
Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluationHepatology, 54
Riccardo Lencioni1, Josep 3 (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSemin Liver Dis, 30
W. Jarnagin, S. Weber, S. Tickoo, J. Koea, S. Obiekwe, Y. Fong, R. DeMatteo, L. Blumgart, D. Klimstra (2002)
Combined hepatocellular and cholangiocarcinomaCancer, 94
Kathryn Fowler, N. Saad, E. Brunt, M. Doyle, M. Amin, N. Vachharajani, B. Tan, W. Chapman (2015)
Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed TherapyAnnals of Surgical Oncology, 22
R. Hoffmann, P. Paprottka, A. Schön, F. Bamberg, A. Haug, E. Dürr, B. Rauch, C. Trumm, T. Jakobs, T. Helmberger, M. Reiser, F. Kolligs (2012)
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged SurvivalCardioVascular and Interventional Radiology, 35
WR Jarnagin, S Weber, SK Tickoo (2002)
Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factorsCancer, 94
J. Camacho, N. Kokabi, M. Xing, H. Prajapati, B. El-Rayes, Hyun Kim (2014)
Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.Journal of vascular and interventional radiology : JVIR, 25 2
Jin Kim, H. Yoon, G. Ko, D. Gwon, Cheol Jang, Ho-Young Song, J. Shin, K. Sung (2010)
Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.Radiology, 255 1
K. Hong, J. McBride, C. Georgiades, D. Reyes, J. Herman, I. Kamel, J. Geschwind (2009)
Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.Journal of vascular and interventional radiology : JVIR, 20 3
Xin Yin, Bo-Heng Zhang, S. Qiu, Z. Ren, Jian Zhou, Xiao-hong Chen, Ying Zhou, Jia Fan (2012)
Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Clinical Features, Treatment Modalities, and PrognosisAnnals of Surgical Oncology, 19
Z. Goodman, K. Ishak, J. Langloss, I. Sesterhenn, L. Rabin (1985)
Combined hepatocellular‐cholangiocarcinoma. A histologic and immunohistochemical studyCancer, 55
Cardiovasc Intervent Radiol (2017) 40:1383–1391 DOI 10.1007/s00270-017-1648-7 CLINICAL INVESTIGATION INTERVENTIONAL ONCOLOGY Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma 1 1 2 1 • • • • Lauren S. Chan Daniel Y. Sze George A. Poultsides John D. Louie 1 1 Mohammed A. Abdelrazek Mohammed David S. Wang Received: 16 November 2016 / Accepted: 4 April 2017 / Published online: 21 April 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017 Abstract before RE showed decreased levels after treatment (median Purpose Combined hepatocellular-cholangiocarcinoma decrease of 72%, range 13–80%). Best hepatic radiological (cHCC-CC) is a rare mixed cell type primary liver cancer response was 60% partial response and 40% stable disease with limited data to guide management. Transarterial by modified RECIST, and 100% stable disease by RECIST radioembolization with yttrium-90 microspheres (RE) is an v1.1. Poor performance status and the presence of emerging treatment option for both hepatocellular carci- macrovascular invasion were identified as predictors of noma and intrahepatic cholangiocarcinoma. This study reduced survival after RE. explored the safety and efficacy of RE for unre- Conclusion RE appears to be a safe and promising treat- sectable cHCC-CC. ment option for patients with unresectable cHCC-CC.
CardioVascular and Interventional Radiology – Springer Journals
Published: Apr 21, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.